Association of melanoma and natalizumab therapy in the Italian MS population: a second case report (Q61657746)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Association of melanoma and natalizumab therapy in the Italian MS population: a second case report (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Antonio Uccelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Gianluigi Mancardi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

M Bedognetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

E Capello

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

5 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

published in

Neurological Sciences

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

181-182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10072-010-0427-x

15 January 2020

exact match

0 references

cites work

Regulation of integrin activity by MIA.

1 reference

12 December 2020

Melanoma complicating treatment with natalizumab for multiple sclerosis

1 reference

12 December 2020

Melanoma incidence in central Italy will go on increasing also in the near future: a registry-based, age-period-cohort analysis.

1 reference

12 December 2020

Melanoma in multiple sclerosis treated with natalizumab: causal association or coincidence?

1 reference

12 December 2020

Melanoma following treatment with alemtuzumab for multiple sclerosis.

1 reference

12 December 2020

Melanoma complicating treatment with natalizumab (tysabri) for multiple sclerosis

1 reference

12 December 2020

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

12 December 2020

Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation.

1 reference

12 December 2020

Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies.

1 reference

12 December 2020

More on melanoma with transdifferentiation

1 reference

12 December 2020

Integrin signaling in malignant melanoma.

1 reference

12 December 2020

10.1007/S10072-010-0427-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052756%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference